Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-25-064678
Filing Date
2025-07-16
Accepted
2025-07-16 16:05:12
Documents
14
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0248993-10ka1_oramed.htm   iXBRL 10-K/A 212940
2 CERTIFICATION ea024899301ex31-1_oramed.htm EX-31.1 3020
3 CERTIFICATION ea024899301ex31-2_oramed.htm EX-31.2 3041
  Complete submission text file 0001213900-25-064678.txt   429056

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ormp-20241231.xsd EX-101.SCH 3063
5 XBRL LABEL FILE ormp-20241231_lab.xml EX-101.LAB 32597
6 XBRL PRESENTATION FILE ormp-20241231_pre.xml EX-101.PRE 16888
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0248993-10ka1_oramed_htm.xml XML 7075
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35813 | Film No.: 251127430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)